Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2019-05-30 | Viscient Biosciences | Seed VC | ||
2019-05-07 | Repair Biotechnologies | Seed VC | $2.15M | Emerging Longevity Ventures, Jim Mellon, and SENS Research Foundation |
2017-12-13 | Theragene Pharmaceuticals | Convertible Note | ||
2017-11-02 | Klotho Therapeutics | Series A | $10M | |
2017-09-25 | Elevian | Seed VC | $5.5M | BOLD Capital Partners, Kizoo Technology Ventures, Stanford-StartX Fund, The Longevity Fund, and WTI Holdings |